extensive testing has proven that recombinant human erythropoietin ( r-huepo ; epogen [ epoetin alfa ] , amgen inc , thousand oaks , ca ) corrects the anemia of end-stage renal disease and eliminates the need for transfusions in virtually all patients .
C0700704
epogen
C0357126
epoetin alfa